Parallel Biologics

About Parallel Biologics

Parallel Biologics is a biotechnology company focused on developing novel therapeutic antibodies. They utilize a proprietary platform to discover and engineer antibodies with enhanced potency, specificity, and drug-like properties. Their pipeline targets a range of diseases, including oncology and autoimmune disorders. The company aims to accelerate the development of life-changing medicines by leveraging advanced biological insights and cutting-edge protein engineering technologies. Parallel Biologics collaborates with academic institutions and pharmaceutical partners to advance its antibody candidates through preclinical and clinical development, ultimately seeking to bring innovative treatments to patients in need.